Diana N Lockwood

5PUBLICATIONS
17CO-AUTHORS
Other European languagesMajor global burdens of diseasePreventative health careAllergy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Oct 20, 2022
Diagnosing and treating leprosy in a non-endemic setting in a national centre, London, United Kingdom 1995-2018.

Diana N Lockwood, Amy McIntosh, Margaret Armstrong

|Oct 13, 2021
Clinical diversity and treatment results in Tegumentary Leishmaniasis: A European clinical report in 459 patients.

Romain Guery, Stephen L Walker, Gundel Harms

|Jun 02, 2021
An assessment of the reported impact of the COVID-19 pandemic on leprosy services using an online survey of practitioners in leprosy referral centres.

Barbara de Barros, Saba M Lambert, Edessa Negera

|Jun 08, 2018
Single-dose rifampicin chemoprophylaxis protects those who need it least and is not a cost-effective intervention.

Diana N J Lockwood, Padebettu Krishnamurthy, Bhushan Kumar

|Mar 31, 2017
AZALEP a randomized controlled trial of azathioprine to treat leprosy nerve damage and Type 1 reactions in India: Main findings.

Diana N J Lockwood, Joydeepa Darlong, Pitchaimani Govindharaj

Pageof 1